NZ's EBOS Group slumps as $2.4 bln Greencross deal fails to proceed

EBOS

22/11/2023 01:24

(Updates with ASX-listed share moves, share volumes)
    ** NZ-listed shares of pharmaceutical products distributor
EBOS Group  EBO.NZ  fall as much as 7.4% to NZ$35.760, their
lowest since Nov 2
    ** Shares on track for their worst day since June 6, if
losses hold
    ** Australia-listed shares of EBOS fall nearly 4% to
A$33.660, set for best daily gains since June 6, if trend holds 
        ** About 131,946 shares change hands, vs 30-day average
volume of 118,961
    ** Co says it would not proceed with a potential major
transaction in animal care segment
    ** Source with direct knowledge of the matter said EBO was
in talks to acquire TPG Capital-backed pets and vets business
Greencross
    ** Local media had reported that EBO would pay A$3.75 bln
($2.44 bln) to acquire Greencross
    ** As of last close, stock down 12.1% this year

    ($1 = 1.5366 Australian dollars)


 (Reporting by Himanshi Akhand and Poonam Behura in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))